RxDoctor Payments Data

Sheryl Miller Long

Family Medicine · Irvine, CANPI 1588600613

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AstraZeneca at 24.7% of the total. Reporting peaked in 2019 at $1,286 and has fallen 93.8% since, to $80 in 2022.

$1,838in general payments, 2019–2025

Across 102 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$454
  • Astellas Pharma US Inc$208
  • Johnson & Johnson$187
  • Lilly USA, LLC$117
  • Novo Nordisk$95
  • Takeda Pharmaceuticals U.S.A., Inc.$93
  • plus $683 from 13 others

What the payments were for

  • Food & beverage$1,830100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,838 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California →

Other family medicine in Irvine

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →